PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1477268
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1477268
Topical Drug Delivery Market, By Formulation, By Route of Administration, By Distribution Channel, By Geography
The topical drug delivery market is estimated to be valued at USD 124.90 Bn in 2024 and is expected to reach USD 229.91 Bn by 2031, growing at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 124.90 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 9.10% | 2031 Value Projection: | US$ 229.91 Bn |
Topical drug delivery refers to the administration of therapeutic compounds directly to the site of action. This localized drug delivery aims to maximize the therapeutic effects while minimizing the systemic side effects. It involves the application of formulations like gels, creams, foams, films, etc. to the skin or mucosal surfaces. Compared to systemic delivery, topical drug administration allows higher drug concentration in the targeted tissue with lower overall doses. This enhances efficacy and safety. The growing demand for pain management and dermatological therapies is a major factor driving interest in topical delivery modalities.
Market Dynamics:
The topical drug delivery market is driven by the growing geriatric population susceptible to various diseases, rising prevalence of dermatological and ophthalmic conditions, and increasing demand for pain management therapies. However, drug permeation issues owing to biological barriers like stratum corneum pose a challenge. On the positive side, ongoing advancements in formulation technologies like nanocarriers, lipid-based systems, and novel polymers are expanding the possibilities and improving permeation. Growing healthcare expenditure in emerging economies also opens up opportunities. The topical drug delivery market has seen significant technological advancements in recent years. New innovations aim to enhance skin permeability for drug delivery while also improving treatment efficacy and patient comfort. One key trend is the development of nano-scale delivery systems. Nanoparticle formulations can help medications penetrate deeper layers of the skin. This overcomes a major barrier for treating dermatological conditions. Liposomes, polymeric nanoparticles, dendrimers, and nano emulsions have all shown promise in transdermal delivery. Researchers are exploring ways to optimize particle size, composition, and surface charge to maximize skin permeation.
Key Features of the Study:
- This report provides an in-depth analysis of the global topical drug delivery market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global topical drug delivery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study includes Johnson & Johnson, Pfizer Inc., Novartis International AG, GSK plc, Bayer AG, Merck & Co., Inc., Sanofi, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Eli Lilly and Company, Galderma Laboratories, L.P., Viatris Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Bausch Health Companies Inc., Taro Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., and Almirall S.A.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global topical drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global topical drug delivery market
Market Segmentation
- By Formulation:
- Liquid Formulations
- Semi-Solid Formulations
- Solid Formulations
- Transdermal Patches
- By Route of Administration:
- Dermal
- Rectal
- Vaginal
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Johnson & Johnson
- Pfizer Inc.
- Novartis International AG
- GSK plc
- Bayer AG
- Merck & Co., Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Eli Lilly and Company
- Galderma Laboratories, L.P.
- Viatris Inc.
- Sun Pharmaceutical Industries Ltd.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Taro Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Ltd.
- Almirall S.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Formulation
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnership Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
4. Global Topical Drug Delivery Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 impact on the market
5. Global Topical Drug Delivery Market, By Formulation, 2019 - 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Liquid Formulations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Semi-Solid Formulations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Solid Formulations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Transdermal Patches
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
6. Global Topical Drug Delivery Market, By Route of Administration, 2019 - 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Dermal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Rectal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Vaginal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
7. Global Topical Drug Delivery Market, By Distribution Channel, 2019 - 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
8. Global Topical Drug Delivery Market, By Region, 2019 - 2031, (USD BN)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD BN)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Johnson & Johnson*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Novartis International AG
- GSK plc
- Bayer AG
- Merck & Co., Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Eli Lilly and Company
- Galderma Laboratories, L.P.
- Viatris Inc.
- Sun Pharmaceutical Industries Ltd.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Taro Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Ltd.
- Almirall S.A.
10. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
